Preliminary results for ViroPharma's phase I hepatitis C orally administered drug HCV-796 demonstrated antiviral effects in adult patients with chronic hepatitis C infection. Release [1]
Links:[1] http://www.primezone.com/newsroom/news.html?d=89526